Do you have a confirmed medical history of asthma?

We are reaching out to volunteers to take part in a clinical trial of a new medicine new medicine being developed to control asthma symptoms. By volunteering you will be helping us to improve current treatments available to other patients like you.

Register your interest in this clinical trial
  • Study summary

You may be suitable to take part in this study if you are aged 18 to 77 (inclusive) and you have mild to moderate asthma, but are otherwise healthy. This study will be carried out at our clinical trials unit at Croydon University Hospital in South London. Study participation will involve one initial screening appointment at our unit to check that you are medically suitable to take part, a one night residential stay at our unit and 4 out-patient visits if you are included in the study.

  • Study dates

Screening appointments will be held up to Friday 3rd October.

Residential stay

Admission: Thursday, 16th October

Dismissal: Friday 17th October

Outpatient visits

Visit 1: Sunday, 26th October
Visit 2: Thursday, 27th November
Visit 3: Thursday, 11th December
Visit 4: Thursday, 8th January

  • Reimbursement for your time

In recognition of the time involved in taking part in this study, you will receive £450 on completion of the study and a discretionary bonus payment of £220 provided you comply fully with all the study requirements. The total amount you could receive is £670. Travel assistance will be provided for the screening visit and study visits if you are included in the study.

  • Speak to our Volunteer Recruitment team

If you are interested in finding out more

Register for this clinical trial

Email asthma@richmondpharmacology.com for details

Or call us weekdays between 09h00 and 17h00 on +44 (0) 208 664 5200 (choose option 1) to speak to a member of our Volunteer Recruitment team.

Ref: ST1_MAY 2014 (web story)

The contents of this email have been approved by an ethics committee. Any response to this advertisement will be recorded. Your response will not place you under any obligation to participate in this trial.

You may be required to remain resident in the unit until resolution of any safety issues, after which you will be discharged from the unit.